Categories: Market News

Neptune Wellness (NASDAQ: NEPT): Q3 2020 Earnings Snapshot

— Neptune Wellness Solutions Inc. (NASDAQ: NEPT) swung to a profit in the third quarter of 2020 from a loss last year, helped by a gain related to a reduction in the fair value of the contingent consideration in connection to SugarLeaf Labs purchase.

— Total revenues jumped by 40% year-over-year to CAD9.18 million. This was driven by the cannabis segment despite a decline in the nutraceutical segment.

— Revenue from the cannabis segment reached CAD2.81 million. The company started the commercial operations of its Cannabis segment in March 2019.

— Revenue from the nutraceutical segment declined by 3% to CAD6.34 million.

— The adjusted EBITDA loss widened from last year, due to the investments made in the cannabis segment to grow the workforce in anticipation of increased sales volume as well as higher salaries and benefits at the corporate level.

— The company launched its hemp-derived wellness products, Forest Remedies and Ocean Remedies, in the US. A similar launch in Canada will be followed once approved by health authorities.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Share
Published by

Recent Posts

Marriott International (MAR) reports higher Q4 FY25 adj. earnings

Marriott International, Inc. (NASDAQ: MAR) on Tuesday reported an increase in adjusted earnings for the…

57 seconds ago

Aramark Holdings Q1 Revenue Tops Estimates; Shares Mixed After Close

Aramark Holdings Corp (NYSE: ARMK) shares closed at about $38.77 on Monday, marking a modest…

20 minutes ago

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

44 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

58 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

1 hour ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago